Understanding the complex biology of AHR activation in cancer

Project Information

CancAHR

Grant agreement ID: 101045257

DOI

10.3030/101045257

EC signature date 13 November 2022

Start date 1 January 2023

End date 31 December 2027

Funded under

• European Research Council (ERC)

Total cost

€ 1 999 925,00

EU contribution

€ 1 999 925,00

Coordinated by

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes

Author(s): Solvay, M; Holfelder, P; Klaessens, S; Pilotte, L; Stroobant, V; Lamy, J; Naulaerts, S; Spillier, Q; Frédérick, R; De Plaen, E; Sers, C; Opitz, CA; Van den Eynde, BJ; Zhu, J
Published in: Journal for ImmunoTherapy of Cancer, 2023, ISSN 2051-1426
Publisher: BMJ Publishing Group
DOI: 10.1101/2023.01.16.524177

Biochemical Pharmacology

Author(s): Opitz, Christiane A.; Holfelder, Pauline; Prentzell, Mirja Tamara; Trump, Saskia
Published in: Biochemical Pharmacology, 2023, ISSN 0006-2952
Publisher: Elsevier BV
DOI: 10.1016/j.bcp.2023.115798